Fig. 3
From: Clinical utility of serum biomarkers in Duchenne muscular dystrophy
Representative serum protein biomarkers that are altered in 4 years old DMD boys. CK-M creatine kinase muscle type, CAMK2D calcium/ calmodulin-dependent protein kinase type II subunit delta; MK12 mitogen-activated protein kinase 12, RET proto-oncogene tyrosine–protein kinase receptor Ret, GDF-11 growth differentiation factor-11; Cadherin-5